Pakistan's listed pharmaceutical sector's earnings were up 3.1x to Rs. 24.8 billion in the calendar year 2024. This jump in ...

Investing in stocks comes with risks. There's no way around that fact. However, some stocks can be less risky than others during certain market conditions. Three Motley Fool contr ...

Researchers from the University of the Philippines Manila recently developed a cost-effective painkiller made from an herbal plant that has long been used by many Filipinos as a home remedy: the yerba ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

US -based pharmaceutical giant Eli Lilly recently launched its weight loss drug Mounjaro in India. Tirzepatide is the generic ...

The establishment of Hua Medicine’s pharmaceutical sales and marketing team resulted in significant sales growth in the first ...

The PBS works by ensuring that medicines listed on its schedule are subsidized by the government. For example, in the last financial year, the PBS handled about 227 million preions. Cost Structure: ...

A long-running struggle in Nigeria against fake medicines has become even harder because widespread economic hardship is driving up demand, experts say.

With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.

By Adeola Bakare In bustling cities like Lagos, Abuja, Port Harcourt, and Kano, a silent public health emergency is unfolding ...

Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine targeting a chronic blood disorder.

Compounding pharmacies have emerged as a crucial player in the evolving landscape of personalized medicine, offering ...